Efficacy of denbufylline in patients wit
β
M. O'Connolly; D. Dierdorf; Dr. W. H. Greb; M.-E. R. Mayer; D. Wolf
π
Article
π
1988
π
John Wiley and Sons
π
English
β 213 KB
The efficacy and tolerance of denbufylline (25 and 50 mg tid for three months) were investigated in 20 inpatients with cerebrovascular disease in a placebo-controlled, doubleblind parallel study. Denbufylline at 50 mg tid significantly improved the mental, emotional, and social capabilities of the p